MMHP
SNY icon

Murphy Middleton Hinkle & Parker’s Sanofi SNY Stock Holding History

Murphy Middleton Hinkle & Parker’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,475
Closed -$1.27M – 208
2025
Q4 		$1.27M Buy
+11,475
New +$569K 0.61% 48

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Murphy Middleton Hinkle & Parker's SNY Position: Q1 2026 in Review

Murphy Middleton Hinkle & Parker sold out of Sanofi (SNY) in Q1 2026, closing a stake of 11,475 shares — an estimated $1.27M sold.

Murphy Middleton Hinkle & Parker first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $1.27M in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Murphy Middleton Hinkle & Parker reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Murphy Middleton Hinkle & Parker sold 11,475 Sanofi shares in Q1 2026, an estimated $1.27M.
  • Murphy Middleton Hinkle & Parker first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
  • Murphy Middleton Hinkle & Parker's Sanofi position peaked at $1.27M in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q1 2026, filed 15 Apr 2026.